Hematology/Oncology/Coagulation
Our research department brings together four specialized research groups working on groundbreaking projects in the fields of haematology, oncology and coagulation disorders. From research into novel immunotherapies and the identification of promising therapeutic target structures to the optimization of diagnostic and treatment procedures for rare congenital immune and blood disorders - our common goal is to sustainably improve the chances of recovery for young patients. Find out more about our projects and the dedicated teams who work every day to develop innovative therapies and customized treatment options.
Prof. Dr. med. Tobias Feuchtinger
Research topics:
Adoptive T-cell transfer of virus-specific T-cells
- interaction of pediatric leukemia and immun cells
- immune therapy of akute leukemia - innovatice CAR T-calls Im
Prof. Dr. Irene Schmid
Research topics:
Clinical studies in children and adolescents with a liver tumor
- miR-492 in hepatoblastoma
- AHR and DRD5 as new therapeutic targets in acute myeloid leukemia with MLL aberration
Prof. Dr. med. Michael Albert
Research topics:
Improving diagnosis of rare inborn errors of immunity and hematopoiesis.
- Improving treatment of rare inborn errors of immunity and hematopoiesis:
- with allogeneic hematopoietic stem cell transplantation, and
- autologous stem cell gene therapy
- Improving treatment of pediatric leukemia with allogeneic hematopoietic stem cell transplantation
Dr. med. Vera Binder
Research topics:
Protective leukemia-niche interactions
- Immune evasion of leukemia via macrophages
- Liquid biopsy for high-risk leukemia
- Zebrafish xenograft model